High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents.

By Junyi Ma, Liang Guo, Steve Fiene, B. Anson, James A. Thomson, T. Kamp, K. Kolaja, B. Swanson, C. January. American Journal of Physiology. Heart and Circulatory Physiology, 2011

777 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Cellular and Molecular Neuroscience, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/88499b49a830a39dd16381e224d8880e47d868ce

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Yasuyuki Ohgino
2. Fumiyuki Hattori
3. M. Sano
4. M. Yoichi
5. S. Tohyama
6. M. Suematsu
7. K. Fukuda
8. S. Yuasa

Citations in the corpus

• Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes. (2013, methodology): “There are several approaches available for obtaining enriched cardiomyocyte populations from human PSCs. Ma et al. (2011) performed genetic-modification-based purification of cardio- myocytes (achieving >98% cardiomyocyte purity) from hiPSC derivatives, using the intrinsicMYH6gene to express…”
• Production of De Novo Cardiomyocytes: Human Pluripotent Stem Cell Differentiation and Direct Reprogramming (2012, neutral): “Indeed, it has been demonstrated that an MYH6blastocidin hiPSC line can be differentiated using simple suspension culture and 10% FBS in DMEM to produce hiPSC-derived cardiomyocytes in commercial quantities (Ma et al., 2011).”